Thank you for taking the time to consider my thoughts and post a stellar reply. I agree and wanted to add that “flair” ... “Speculation... but...”
I think you pointed out some great facts there ... Also back in that last Dr. Yo interview when Dr. Yo asked that question on “uplisting” (a question I thought was out-of-the-blue and a bit absurd to be honest).... I liked that Javitt answered and distanced NeuroRx from Relief in saying “oh you mean for Relief? Not sure what they are doing ... we are privately held.”
Dr. Javitt has been very careful with his language... gave us the good the bad & the ugly, and now it appears we might (MIGHT) have a positive development on the US side with Neuro where Dr. Javitt can speak more candidly on the data THEY have submitted to the FDA.
That’s JMHO, spitballing off what you have said here. It IS curious that this is coming from NeuroRX and not another avenue... ONE Week after they submitted data to FDA..... It would make sense for EUA to drop during a US business day since this is happening through Neuro... And yes they’d certainly have to halt the Swiss!
I can’t see it being delivered during Swiss trading hours with RLFTF being halted, since this is NeuroRx’s “baby” in the USA. Thanks for the food for thought Uncle Gee Gee!
I can assure you I am absolutely not excited based on this possibly “baseless” dot connecting... But I don’t think it’s baseless and actually, now that I think about, I am pretty excited ;) Ha!
$RLFTF
